Chest Diseases Dept, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Oxford Pleural Unit, Oxford Respiratory Trials Unit, University of Oxford, Oxford, UK.
Eur Respir Rev. 2020 Apr 29;29(156). doi: 10.1183/16000617.0136-2019. Print 2020 Jun 30.
Physician-led thoracic ultrasound (TUS) has substantially changed how respiratory disorders, and in particular pleural diseases, are managed. The use of TUS as a point-of-care test enables the respiratory physician to quickly and accurately diagnose pleural pathology and ensure safe access to the pleural space during thoracentesis or chest drain insertion. Competence in performing TUS is now an obligatory part of respiratory speciality training programmes in different parts of the world. Pleural physicians with higher levels of competence routinely use TUS during the planning and execution of more sophisticated diagnostic and therapeutic interventions, such as core needle pleural biopsies, image-guided drain insertion and medical thoracoscopy. Current research is gauging the potential of TUS in predicting the outcome of different pleural interventions and how it can aid in tailoring the optimum treatment according to different TUS-based parameters.
医生主导的胸腔超声（TUS）极大地改变了呼吸疾病，特别是胸膜疾病的管理方式。TUS 作为一种即时检测手段，使呼吸科医生能够快速准确地诊断胸膜病变，并确保在进行胸腔穿刺或胸管插入时安全进入胸膜腔。在世界不同地区，TUS 操作能力现在已成为呼吸专科培训计划的必修部分。具有更高能力的胸膜科医生在规划和执行更复杂的诊断和治疗干预措施（如芯针胸膜活检、影像引导引流管插入和内科胸腔镜检查）时，常规使用 TUS。目前的研究正在评估 TUS 在预测不同胸膜干预措施结果方面的潜力，以及它如何根据不同的基于 TUS 的参数来帮助制定最佳治疗方案。
